Regeneron Pharmaceuticals (REGN) EPS (Basic) (2009 - 2026)
Regeneron Pharmaceuticals' (REGN) quarterly EPS (Basic) came in at $6.99 in Q1 2026, down 7.74% year-on-year from $7.58 in Q1 2025, and down 13.4% quarter-over-quarter from $8.07 in Q4 2025.
Regeneron Pharmaceuticals (REGN) EPS (Basic) (2009 - 2026) Analysis & Trends
Regeneron Pharmaceuticals' EPS (Basic) history runs 18 years deep, the most recent figure standing at $6.99 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 7.74% year-over-year to $6.99 in Q1 2026; TTM through Mar 2026 was $42.53, a 0.87% increase from a year earlier, with the FY2025 full-year figure at $43.07, up 5.31% from the prior year.
- EPS (Basic) eased to $6.99 in Q1 2026 per REGN's latest filing, from $8.07 in the prior quarter.
- Across five years, EPS (Basic) topped out at $14.09 in Q3 2025 and bottomed at $6.7 in Q1 2024.
- The 5-year median for EPS (Basic) is $9.12 (2022), against an average of $9.9.
- Across the five-year window, EPS (Basic) tumbled 73.24% in 2022 and soared 46.4% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at $11.18 in 2022, then decreased by 2.77% to $10.87 in 2023, then dropped by 21.74% to $8.51 in 2024, then declined by 5.06% to $8.07 in 2025, then dropped by 13.4% to $6.99 in 2026.
- Per Business Quant, the three latest REGN EPS (Basic) figures stand at $6.99 (Q1 2026), $8.07 (Q4 2025), and $14.09 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 1.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.99 |
| Dec 31, 2025 | 8.07 |
| Sep 30, 2025 | 14.09 |
| Jun 30, 2025 | 13.24 |
| Mar 31, 2025 | 7.58 |
| Dec 31, 2024 | 8.51 |
| Sep 30, 2024 | 12.40 |
| Jun 30, 2024 | 13.25 |
| Mar 31, 2024 | 6.70 |
| Dec 31, 2023 | 10.87 |
| Sep 30, 2023 | 9.48 |
| Jun 30, 2023 | 9.05 |
| Mar 31, 2023 | 7.64 |
| Dec 31, 2022 | 11.18 |
| Sep 30, 2022 | 12.31 |
| Jun 30, 2022 | 7.90 |
| Mar 31, 2022 | 9.12 |
| Dec 31, 2021 | 21.09 |
| Sep 30, 2021 | 15.37 |
| Jun 30, 2021 | 29.51 |